Christopher Peetz - 03 Feb 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
03 Feb 2025
Transactions value $
-$438,921
Form type
4
Filing time
04 Feb 2025, 17:30:12 UTC
Previous filing
27 Jan 2025
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$439K -9.1K -7.28% $48.22 116K 03 Feb 2025 Direct F1
holding MIRM Common Stock 209K 03 Feb 2025 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.